The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (9 analysts) rates it buy, with a mean price target of $35.
York Space Systems, Inc.
YSS · the NYSE · USD · Market cap $1.2B · 710 employees
York Space Systems, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-04
Screened 2026-09-04 · the tape above runs as of 19:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
York Space Systems, Inc. holds its Markdown at $8.96. The statistical read favours the buyers, held for 3 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 3 days |
| Price at the screen | $8.96 |
| Valuation | N/A trailing · -22.40 forward price to earnings |
| Values screen | FAIL · score 30.0 |
Five Screens, Shown in Full
Does not pass. Prohibited business activity: Aerospace & Defense
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited business activity: Aerospace & Defense | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-04 screen. The gold marker is the market price at the same screen. A 73.0% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Buy. The average target sits +73% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDefence satellites fail the ethical screen outright
York Space Systems builds satellites and software for national security work that governments cannot do without. The numbers show revenue edging up 10 percent but margins stuck at minus 47 percent and a forward multiple of 33.6 times earnings. That combination already looks stretched even before the ethical verdict lands.
We pass for one clear reason. The business sits squarely inside prohibited aerospace and defence activity, which our screen rejects without debate. Analyst targets above thirty dollars and a modest stated margin of safety change nothing once that line is crossed.
The real exposure sits in thin profitability and heavy reliance on government budgets that can shift with policy. This is exactly what the screen is for. Analysis, not advice.
| Forward P/E | -22.4x |
| EPS, trailing | -2.01 |
| EPS, forward | -0.40 |
| Revenue growth | +10.4%steady growth |
| Profit margin | -50.1%currently unprofitable |
| Debt to equity | 0.10minimal debt: a conservative balance sheet |
| Current ratio | 5.34comfortably covers its short-term bills |
| Short interest, float | 0.08% |
| 52-week range | 8.38 - 44.54 |
| Market cap | $1.2B |
| Employees | 710 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeYSS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 62.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (9 analysts) rates it buy, with a mean price target of $35.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (9 analysts) rates it buy, with a mean price target of $35.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $35.88 | -23.0% | · | $770 | -23.0% |
| 2 months | $33.32 | -17.1% | · | $829 | -17.1% |
| 3 months | $19.98 | +38.2% | · | $1,382 | +38.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever YSS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.